postnecrotic

postnecrotic的基本解释

-

[医] 坏死后的

与postnecrotic相关的网络例句 [注：此内容来源于网络，仅供参考]

Methods 19patients（68±9）years with postnecrotic left ventricular dysfunction（ejection fraction31.7%±5.4%）were studied to examine the benefit of adding60mg a day of trimetazidine for3months to the classical therapy.

19例（68±9）岁确诊为缺血性心肌病（左心室射血分数0%）的患者在常规治疗的基础上加用每日60mg曲美他嗪治疗3个月，随诊观察患者临床情况以及超声心动图指标的变化。

objective trimetazidine has shown anti-ischemic properties to improve exercise tolerance without haemodynamic effects and direct cyto protective effect on the myocardium.however,it is not clear whether trimetazidine has beneficially effect on severe ischemic cardiomyopathy.methods 19patients（68±9）years with postnecrotic left ventricular dysfunction（ejection fraction31.7%±5.4%）were studied to examine the benefit of adding60mg a day of trimetazidine for3months to the classical therapy.the assessment included clinical evaluation,electrocardiography and echocardiography.results after adding60mg a day of trimetazidine for3months,attack of angina was relieved and dyspnea was improved（p.05）.but heart rate,systolic blood pressure,rate pressure product,ejection fraction,left ventricular volume and global wall motion index were not changed.conclusion trimetazidine seems to improve clinical status while can not change oxygen supply-to-demand ratio without adverse effects in patients on severe ischemic carˉdiomyopathy.

目的 曲美他嗪是一种新型的抗心肌缺血的药物，能够改善患者的运动耐量和心肌的直接保护作用同时并没有血流动力学效应。但目前对于严重缺血性心肌病患者的临床治疗价值还需要进一步观察。方法 19例（68±9）岁确诊为缺血性心肌病（左心室射血分数0%）的患者在常规治疗的基础上加用每日60mg曲美他嗪治疗3个月，随诊观察患者临床情况以及超声心动图指标的变化。结果 19例患者均可耐受在常规治疗基础上加用每日60mg曲美他嗪的治疗，随诊发现患者心绞痛发作明显减少，运动耐量明显改善。同时患者心率、收缩压、心率血压乘积、左心室射血分数、左心室容量以及整体室壁运动指数无明显改变。结论缺血性心肌病的患者在常规治疗基础上加用曲美他嗪是安全的，同时其能明显改善患者的临床状态，而这种作用并不改变心肌氧的供求比值。

The ex perimental results indicate that the rats of the experimental group all manifested with postnecrotic cirrho sis, mainly forming pseudolobules, the third stage lesions; deep lingual venous pressure elevated which was correlated with that of portal pressure, portal blood flow decreased predominantly, as compare...

认为肝硬变门脉高压性瘀证的舌脉粗张与细络瘀血主要是因门脉血经门—腔侧支循环回流入上腔静脉，引起上腔静脉阻力增大，压力增高，导致舌的静脉系统回流受阻，舌深静脉压力升高所致。

与postnecrotic相关的网络解释 [注：此内容来源于网络，仅供参考]

postnecrotic cirrhosis：坏死后肝硬化

坏疽性阑尾炎, gangrenous appendicitis? | 坏死后肝硬化, postnecrotic cirrhosis? | 坏死性胰腺炎, necrotizing pancreatitis?

postnecrotic cirrhosis：坏死性后肝硬变

portal-systemic encephalopathy 门脉系统性脑病 | postnecrotic cirrhosis 坏死性后肝硬变 | prehepatic nonhemolytic jaundice 肝前非溶血性黄疸

postnecrotic cirrhosis：坏死后肝硬变

脾 肿 大 splenomegaly | 坏死后肝硬变 postnecrotic cirrhosis | 胆汗性肝硬变 biliary cirrhosis

postnecrotic cirrhosis：坏死后性肝硬化

门脉性肝硬化 portal cirrhosis | 坏死后性肝硬化 postnecrotic cirrhosis | 胆汁性肝硬化 biliary cirrhosis

postnecrotic cirrhosis of liver：坏死后性肝硬化

* portal cirrhosis of liver 门脉性肝硬化 | * postnecrotic cirrhosis of liver 坏死后性肝硬化 | * portal hypertension 门脉高压